Regresar

Drug ontology for the public mexican health system

Abstract:

With the emergence of the COVID-19 pandemic, a growing need has emerged for well-structured medical knowledge bases that are accessible to physicians, specialists, pharmacists, patients, and the general public. This article describes the process of development and evaluation of an Mexican Drug Ontology4 with information from the “Basic Table and Catalog of Medicines” published by the Secretary of Public Health. The resulting ontology is composed by 64 classes, 5 object properties, 18 data properties, and has a value ALCQ(D) of “DL Expressivity” measure. The evaluation ontology was carried out in two ways: through the competence of the model and through the review of the quality criteria.